Eritel LN 80 Tablet is a combination antihypertensive medication containing Cilnidipine 10 mg and Telmisartan 80 mg, indicated for the management of essential hypertension. Cilnidipine, a dihydropyridine calcium channel blocker, exerts its antihypertensive effect by inhibiting L-type and N-type calcium channels, resulting in vasodilation of peripheral arteries and reduction of sympathetic nerve activity. Telmisartan, an angiotensin II receptor blocker (ARB), selectively antagonizes the AT1 receptor, thereby inhibiting the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to decreased blood pressure and reduced cardiovascular risk. The combination of these two agents provides complementary mechanisms of action, enhancing blood pressure control while minimizing adverse effects commonly associated with monotherapy. Eritel LN 80 is typically prescribed for patients requiring effective blood pressure reduction to prevent complications such as stroke, myocardial infarction, and renal impairment. It is generally well tolerated, with common side effects including dizziness, headache, and mild peripheral edema. Caution is advised in patients with hepatic or renal impairment, and it should be used under medical supervision with regular monitoring of blood pressure and renal function. This combination therapy offers a convenient and efficacious option for long-term hypertension management.

Dosage & How to Use